Singhal Lab
Maternal-Infant Outcomes Study
Next Generation Effects of Obesity Treatments
About the Study
Brief Summary
This study evaluates the effects of commonly used obesity treatments, glucagon-like peptide-1 analogs (GLP-1s) and sleeve gastrectomy (SG), on glucose metabolism and insulin resistance during pregnancy and its effects on the baby’s metabolism. The goal is to determine how obesity treatments impact maternal and fetal health, with a focus on long-term effects for future generations.
Keywords
Obesity treatments, pregnancy, sleeve gastrectomy, GLP-1
Study Type
Observational
Eligibility
- Are in your second half of pregnancy
- Struggle with weight issues OR have received treatment to manage weight (metabolic bariatric surgery or GLP-1 medication) prior to pregnancy
Study Participation
- Three study visits: (1) during the second half of pregnancy, (2) delivery and post-natal, (3) three months postpartum.
- You will receive up to $200 for participating in the study. Parking will be paid.
Contact Ashley Huynh, Clinical Research Coordinator, at or .
